Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stella ChemifaSLAHF 79 3-Year EBITDA Growth Rate is 8.40% as of Mar. 2026, which is 87% above its 10-year median of 4.50. GuruFocus rates SLAHF with a GF Score™ of 79/100 and a GF Value™ of $17.64. The stock has 2 warning signs investors should review. Among 1,407 Chemicals companies, Stella Chemifa ranks better than 63.61% on this metric.
During the past 12 months, Stella Chemifa's average EBITDA Per Share Growth Rate was 5.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 8.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -0.60% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 2.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Stella Chemifa was 12.00% per year. The lowest was -10.50% per year. And the median was 4.50% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Stella Chemifa 3-Year EBITDA Growth Rate Related Terms
SLAHF vs LIN, SHW, ECL: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, Stella Chemifa's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stella Chemifa 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Stella Chemifa's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Stella Chemifa's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 8.40% mean?
Stella Chemifa (SLAHF) has a 3-Year EBITDA Growth Rate of 8.40% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Stella Chemifa and its competitors. This is 87% above median its historical median of 4.50. According to the industry distribution chart, Stella Chemifa ranks #512 out of 1407 companies in the Chemicals industry, placing it in the top 36.4%.
Is Stella Chemifa's 3-Year EBITDA Growth Rate too high?
Stella Chemifa's current 3-Year EBITDA Growth Rate of 8.40% is 87% above median its 10-year median of 4.50. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.90. Stella Chemifa's value of 8.40% is 833.3% above this industry median. Based on the distribution chart, Stella Chemifa ranks #512 out of 1407 companies in the Chemicals industry, which is above the industry midpoint. Overall, Stella Chemifa has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Stella Chemifa's 3-Year EBITDA Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, Stella Chemifa ranks #512 out of 1407 companies for 3-Year EBITDA Growth Rate. This puts Stella Chemifa in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 0.90. Stella Chemifa's value of 8.40% is 833.3% above this benchmark. While the company's 10-year median is 4.50 vs. the industry median of 0.90, Stella Chemifa has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.90, based on 1,407 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stella Chemifa's current 3-Year EBITDA Growth Rate of 8.40% is 833.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Stella Chemifa and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stella Chemifa's current 3-Year EBITDA Growth Rate is 8.40%, which is 87% above median its own 10-year median of 4.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stella Chemifa stock overvalued right now?
Stella Chemifa (SLAHF) has a current 3-Year EBITDA Growth Rate of 8.40%. The stock's GF Value™ is $17.64, compared to a current price of $21.90 — trading 24.1% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 8.40%, which is 87% above median its 10-year median of 4.50 and 833.3% above the Chemicals industry median of 0.90. Stella Chemifa's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Stella Chemifa (SLAHF), the current 3-Year EBITDA Growth Rate is 8.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stella Chemifa (SLAHF) Overvalued in 2026?
Based on GuruFocus' analysis, Stella Chemifa stock appears to be overvalued.
The current stock price of $21.90 is trading 24.1% above its estimated GF Value™ of $17.64.
Key valuation signals for SLAHF:
3-Year EBITDA Growth Rate: 8.40% (87% above median its 10-year median of 4.50)
GF Value™: $17.64 vs. price of $21.90 (24.1% above fair value)
Industry Position: 833.3% above the Chemicals median (#512 of 1407)
No single metric tells the full story. See the SLAHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stella Chemifa Corp engages in the manufacture, supply, and sale of high-purity chemicals. Its operations are carried out through the following segments: High-Purity Chemicals, Transportation, Medical, Cosmetics, Energy Management and Other. The High-Purity Chemicals unit deals with the production and sale of high-purity chemicals. Transportation services handle the transport, storage, and customs duties of chemicals. The Medical unit manages pharmaceutical research. Additionally, the firm is involved in the sale of cosmetics, dealing with network related equipment and software development, insurance agency, automobile maintenance, energy maintenance system, and Moonlight (phosphorescent products) businesses.
79GF Score
Get the complete analysis for SLAHF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SLAHF has been successfully added to your 
